The broad and long term objectives of this research application focuses on rapid biodosimetry and mitigation of radiation injury as well as advancing education in this area. Many individuals believe that the single greatest threat to America is nuclear proliferation and the possibility of a nuclear device detonation on American soil. This center grant application will address the medical needs that would arise should such an event occur. Each program is led by a team of internationally renowned investigators. Many of the principal investigators have a long history of studies on normal tissue responses to radiation injury. While some project PIs are not radiation scientists, the organization of the Center is such that broad based expertise is drawn from all aspects of radiation sciences. Eminent faculty in the areas of radiation biology, radiation oncology and physics are leaders and active participants in this center. This organization provides an infrastructure that brings experts outside the field of radiation sciences into the center in a way that will maximize the likelihood that they will be successful in developing therapies or diagnostics pertinent to the tasks at hand. These investigators have united to form a comprehensive, inclusive, inter-institutional, and interdisciplinary Center for Medical Countermeasures against Radiation (CMCR). The overarching themes are those of: 1) Novel biodosimetry methods for rapid screening, 2) Mitigation of normal tissue injury with focus on: a.) the immune system, b.) lung, c.) gastrointestinal tract and, d.) hematopoiesis. Thus, the broad scientific specific aims are as follows:
Aim 1 : To develop diagnostic tests for rapid and effective biodosimetry based on optically stimulated luminescence and on DNA based arrays. This will be accomplished by support of work in Program 1.
Aim 2 : Development of novel, safe and effective drugs or candidate molecules for mitigation of radiation injury.
This aim will be accomplished through work on Programs 2 and 3.
Aim 3 : Development of novel, safe and effective drugs or candidate molecules for enhancing immune recovery following exposure to radiation. This will be accomplished under Program 4. All the cores of the center will support the work to achieve the deliverables for Aim 1, 2 and 3. Equally important is the expertise of this group of investigators who are committed to an educational program to train young investigators in this difficult area.
These aims fully support the mission of identifying and developing deliverables that will mitigate the effects of exposure to irradiation while following the NIH roadmap.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Program--Cooperative Agreements (U19)
Project #
5U19AI067798-04
Application #
7490941
Study Section
Special Emphasis Panel (ZCA1-SRRB-E (O1))
Program Officer
Ramakrishnan, Narayani
Project Start
2005-08-31
Project End
2010-07-31
Budget Start
2008-08-01
Budget End
2009-07-31
Support Year
4
Fiscal Year
2008
Total Cost
$4,729,813
Indirect Cost
Name
Duke University
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
044387793
City
Durham
State
NC
Country
United States
Zip Code
27705
Cline, John Mark; Dugan, Greg; Bourland, John Daniel et al. (2018) Post-Irradiation Treatment with a Superoxide Dismutase Mimic, MnTnHex-2-PyP5+, Mitigates Radiation Injury in the Lungs of Non-Human Primates after Whole-Thorax Exposure to Ionizing Radiation. Antioxidants (Basel) 7:
Farris, Michael; McTyre, Emory R; Okoukoni, Catherine et al. (2018) Cortical Thinning and Structural Bone Changes in Non-Human Primates after Single-Fraction Whole-Chest Irradiation. Radiat Res 190:63-71
Naqvi, Ibtehaj; Gunaratne, Ruwan; McDade, Jessica E et al. (2018) Polymer-Mediated Inhibition of Pro-invasive Nucleic Acid DAMPs and Microvesicles Limits Pancreatic Cancer Metastasis. Mol Ther 26:1020-1031
Ghandhi, Shanaz A; Turner, Helen C; Shuryak, Igor et al. (2018) Whole thorax irradiation of non-human primates induces persistent nuclear damage and gene expression changes in peripheral blood cells. PLoS One 13:e0191402
Castle, Katherine D; Daniel, Andrea R; Moding, Everett J et al. (2018) Mice Lacking RIP3 Kinase are not Protected from Acute Radiation Syndrome. Radiat Res 189:627-633
Fanning, K M; Pfisterer, B; Davis, A T et al. (2017) Changes in microvascular density differentiate metabolic health outcomes in monkeys with prior radiation exposure and subsequent skeletal muscle ECM remodeling. Am J Physiol Regul Integr Comp Physiol 313:R290-R297
Swanson, Karen V; Junkins, Robert D; Kurkjian, Cathryn J et al. (2017) A noncanonical function of cGAMP in inflammasome priming and activation. J Exp Med 214:3611-3626
Kurkjian, Cathryn J; Guo, Hao; Montgomery, Nathan D et al. (2017) The Toll-Like Receptor 2/6 Agonist, FSL-1 Lipopeptide, Therapeutically Mitigates Acute Radiation Syndrome. Sci Rep 7:17355
Racioppi, Luigi; Lento, William; Huang, Wei et al. (2017) Calcium/calmodulin-dependent kinase kinase 2 regulates hematopoietic stem and progenitor cell regeneration. Cell Death Dis 8:e3076
Himburg, Heather A; Doan, Phuong L; Quarmyne, Mamle et al. (2017) Dickkopf-1 promotes hematopoietic regeneration via direct and niche-mediated mechanisms. Nat Med 23:91-99

Showing the most recent 10 out of 197 publications